Skip to content

Faculty profile

Kevin Schwartzman

Back to faculty
ResearcherUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.

Latest papers

  • Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort Study.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019

  • Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults.

    The New England journal of medicine · 2018

  • Safety and Side Effects of Rifampin versus Isoniazid in Children.

    The New England journal of medicine · 2018

All 3 publications

Latest funding

  • From Patient to Policy: Using data to drive TB elimination in Canada's foreign born population

    CIHR · 2016 · Principal investigator

    $1,208,699
All 1 grants and awards
Something wrong or missing on this profile? Suggest a correction